Orchestra BioMed Holdings, Inc. Ordinary Shares (OBIO) is a publicly traded Healthcare sector company. As of September 20, 2026, OBIO trades at $6.05 with a market cap of $365.44M and a P/E ratio of -7.04. OBIO moved +4.84% today. Year to date, OBIO is +46.51%; over the trailing twelve months it is +142.23%. Its 52-week range spans $2.20 to $6.30. Analyst consensus is strong buy with an average price target of $10.25. Rallies surfaces OBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest OBIO news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $6.05 |
| Market Cap | $365.44M |
| P/E Ratio | -7.04 |
| EPS | $-0.86 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.30 |
| 52-Week Low | $2.20 |
| Volume | 473.76K |
| Avg Volume | 0 |
| Revenue (TTM) | $31.98M |
| Net Income | $-59.03M |
| Gross Margin | 99.51% |
4 analysts cover OBIO: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $10.25.